Technology Reference / Containment & Specialized Processing / Lateral-Flow Assay & Kit Assembly

Containment & Specialized Processing

Lateral-Flow Assay & Kit Assembly

Manufacturing rapid diagnostic strips that read a sample by capillary flow — and kitting the cassette, buffer, and instructions around them. Performance is built into the strip; whether the user gets a correct result is built into the kit.

Containment & Specialized ProcessingThe family this step lives in — specialized, contained manufacturing for products, like diagnostic devices, that ordinary lines cannot make.See the other containment & specialized processing technologies Fermentation & BioproductionUpstream — the antibodies, antigens, and conjugate the strip reads on are biologically produced before the assay is built.See the fermentation & bioproduction technologies Labeling, Secondary Packaging & LogisticsDownstream — the finished kits are labeled, co-packed, and moved, often under a cold chain, to the point of use.See the labeling & logistics technologies

What it is

A strip that reads a sample — and the kit that makes it usable.

Lateral-flow assay manufacture and kitting builds rapid diagnostic tests that work by capillary flow — a sample wicks along a nitrocellulose strip past antibody/antigen lines that develop a visible signal — plus assembly of the surrounding kit: cassette, collection device, buffer, instructions, packaging. It spans two very different jobs: a sensitive biological manufacturing step (the strip) and a kit-assembly and packaging step.

Those two halves fail in different ways and need different controls — which is exactly why an under-controlled kit can wrap a perfectly good strip in a result the user can’t trust.

The levers are reagent/lot control, striping and lamination precision, desiccant/moisture control, and lot-linked kit assembly. The strip’s performance is set by the reagents and the precision of the striped lines; the kit’s reliability is set by whether the right components, in the right lots, reach the user with the moisture barrier intact.

Reagents are prepared and characterized, the membrane striped and dried, pads laminated and the card slit, strips assembled into cassettes and pouched with desiccant, then kitted with collection device, buffer, and instructions — all lot-linked.

Process flow

Reagents (antibodies/antigens, conjugate) prepared and characterized

Nitrocellulose membrane striped (test/control lines) and dried under controlled conditions

Conjugate pad, sample pad, and absorbent pad laminated; the card slit into strips

Strips assembled into cassettes; cassettes pouched with desiccant

Kitted with collection device, buffer, instructions, and packaging; lot-linked

→

Packaged rapid-test kits

The leversReagent/lot control, striping and lamination precision, desiccant/moisture control, and lot-linked kit assembly.

Why it matters

The strip sets performance; the kit decides whether the user gets it.

Performance — sensitivity, specificity, the absence of false results — is built into reagent and membrane manufacturing and proven by validation. But the kit assembly governs whether the user actually gets a correct result: the wrong buffer, a missing desiccant (moisture kills the strip silently), a confusing instruction sheet, or mismatched component lots all degrade real-world accuracy no matter how good the strip is.

For a regulated diagnostic, the performance claims, controls, and lot traceability are the substance — an under-controlled kit is an unreliable test sold as a reliable one. The discipline is validated assay performance matched to the claim, reagent and membrane lot control and stability, adequate desiccant/moisture protection, per-kit component lot linkage, a control line that truly validates each run, and clear instructions with an honest intended-use and regulatory status.

21 CFR 820 · device QMSRThe FDA quality system regulation for medical devices, now harmonized as the QMSR, governs a lateral-flow test as a device — design controls, production and process controls, and records that trace each lot back to how it was built.

21 CFR 809 · IVD labelingThe in-vitro diagnostic labeling rule sets what the kit must tell the user — intended use, the procedure, limitations, and how to read the result — because a test is only as reliable as the instructions and buffer shipped with it.

21 CFR 820.80 · acceptance activitiesSets the acceptance checks each kit clears before release — incoming materials, in-process strips, and the finished device are inspected or tested against defined criteria — so a lot ships only after it passes, and a weak membrane or missed stability check is caught before it leaves.

ISO 13485The international quality-management standard for medical devices — the framework most diagnostic manufacturers certify to, and the one that carries a kit built for one market into others.

Governed as a medical device/IVD under 21 CFR 820 (QMSR) and 809 labeling; acceptance activities under 820.80 and ISO 13485 anchor the rest.

How it compares

Why a maker chooses lateral flow — and what they trade.

Lateral flow is rapid, cheap, and point-of-care. Knowing what it was chosen over tells you what the test prioritized.

vs.

Lab-based (ELISA / PCR)

Lab methods are more sensitive and quantitative.

The tradeThey need instruments and time; lateral flow is rapid, point-of-care, qualitative or semi-quantitative.

vs.

Molecular point-of-care

Molecular POC is more sensitive.

The tradeIt’s costlier and more complex; lateral flow is cheap and simple.

vs.

Strip-only vs. full kit

A bare strip needs separate components.

The tradeA complete kit controls the whole user workflow — and the accuracy claims that ride on it.

Where it tends to go wrong

The gaps a reviewer looks for on a rapid-test kit.

None of these are exotic. They’re the quiet places a diagnostic’s real-world accuracy erodes — recognizable the moment you’ve built a kit.

Assay performance isn’t validated or isn’t matched to the claim — sensitivity/specificity, false-positive/negative rates.

Reagent/membrane lot control and stability are weak — performance drifts by lot.

Desiccant/moisture protection is inadequate — moisture degrades the strip silently.

Component lots (strip, buffer, device) aren’t linked or traceable per kit.

A built-in procedural/control line doesn’t actually validate each run.

Instructions and interpretation are unclear, driving user error — or intended-use/regulatory status is overstated.

If this is your operation

Six things to check against your own records.

Not an audit — a read you can run yourself before anyone else does. Pull the validation and a recent kit lot.

Ask for the assay validation (sensitivity, specificity, false rates) against the claim.

Check reagent/membrane lot control and stability data.

Confirm desiccant/moisture protection in the pouch.

Review per-kit component lot linkage and traceability.

Look at whether the control line truly validates each run.

Verify instruction clarity and that the regulatory/intended-use status matches the claims.

Applications

The same build, across very different tests.

The analyte changes — the discipline never does: validate the assay, control the lots, protect the strip, link the kit.

Diagnostics

Infectious-disease & clinical tests

Rapid antigen and antibody tests where validated sensitivity/specificity and a working control line carry the diagnostic claim.

Consumer health

Home & OTC test kits

Pregnancy, fertility, and home health kits where instruction clarity and component lot-linkage govern real-world accuracy.

Food & supplement

Allergen & contaminant strips

Lateral-flow strips for allergen, mycotoxin, or contaminant screening, where reagent lot control sets reliability.

Specialty

Veterinary & environmental kits

Veterinary and environmental rapid tests built and kitted to the same design-control and traceability discipline.

Ways to put this to work

Know the process. Now decide how far to take it.

These doors connect to this technology. None outranks another — pick the one that fits where you are.

Learn it

Training

A course on lateral-flow assay manufacture and kitting and the standard it has to meet — so your team understands assay validation, lot control, and design controls before they run or review the step.

Browse training

Check one record

Service

Send us one record from this step — an assay validation, a lot-stability study, a kit lot-linkage record — and get a written read on whether it holds up, and what would close the gap.

See services

Grade your coverage